Viewing Study NCT06506292


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-02-04 @ 3:00 AM
Study NCT ID: NCT06506292
Status: RECRUITING
Last Update Posted: 2024-07-17
First Post: 2024-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adebrelimab (SHR-1316) View
None XELOX View
None GC/GEJC View
Keywords: